MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Начало・Списък с акции・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Затворен

1.35 3.05

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.34

Максимум

1.35

Ключови измерители
By Trading Economics
Приходи	2.7M -24M
EPS	-0.354
Служители	49
EBITDA	-5.3M -28M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+102.27% upside

Дивиденти
By Dow Jones
Следващи печалби	7.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-8.4M 73M
Предишно отваряне	-1.7
Предишно затваряне	1.35

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

1.43 / 1.6 Подкрепа & съпротива

Pliant Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

2.04.2026 г., 17:11 ч. UTC

Значими двигатели на пазара

Значими събития в новините

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2.04.2026 г., 17:10 ч. UTC

Значими събития в новините

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

3.04.2026 г., 00:00 ч. UTC

Значими събития в новините

How Insulated Is the U.S. Economy From the Iran War? -- WSJ

2.04.2026 г., 23:47 ч. UTC

Пазарно говорене

Значими събития в новините

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2.04.2026 г., 21:01 ч. UTC

Значими събития в новините

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2.04.2026 г., 20:59 ч. UTC

Придобивния, сливания и поглъщания

Starbucks and Boyu Capital Finalize China JV

2.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

2.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

2.04.2026 г., 20:41 ч. UTC

Печалби

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2.04.2026 г., 20:32 ч. UTC

Пазарно говорене

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2.04.2026 г., 20:30 ч. UTC

Придобивния, сливания и поглъщания

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2.04.2026 г., 20:09 ч. UTC

Пазарно говорене

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2.04.2026 г., 20:01 ч. UTC

Придобивния, сливания и поглъщания

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2.04.2026 г., 19:46 ч. UTC

Пазарно говорене

Is Oil the New GameStop? -- Market Talk

2.04.2026 г., 19:35 ч. UTC

Пазарно говорене

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2.04.2026 г., 19:29 ч. UTC

Придобивния, сливания и поглъщания

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2.04.2026 г., 19:24 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2.04.2026 г., 19:20 ч. UTC

Пазарно говорене

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2.04.2026 г., 19:01 ч. UTC

Придобивния, сливания и поглъщания

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2.04.2026 г., 19:00 ч. UTC

Придобивния, сливания и поглъщания

Union Pacific: Agreement Reached With American Train Dispatchers Association

2.04.2026 г., 18:24 ч. UTC

Придобивния, сливания и поглъщания

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2.04.2026 г., 17:44 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2.04.2026 г., 17:32 ч. UTC

Значими събития в новините

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2.04.2026 г., 17:26 ч. UTC

Печалби

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2.04.2026 г., 17:17 ч. UTC

Пазарно говорене

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2.04.2026 г., 17:09 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Pliant Therapeutics Inc Прогноза

Ценова цел

By TipRanks

102.27% нагоре

12-месечна прогноза

Среден 2.67 USD 102.27%

Висок 3 USD

Нисък 2 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Pliant Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

5 ratings

Купи

Задържане

Продай

Според 5 анализатори, дали борсови рейтинги на Pliant Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

1.43 / 1.6Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.